A carregar...
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
BACKGROUND: Among diabetics, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality, and progression of their underlying disease. Finerenone is a novel, non-steroidal, selective mineralocorticoid-receptor antagonist which has shown to reduce albuminuri...
Na minha lista:
| Publicado no: | Am J Nephrol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6888890/ https://ncbi.nlm.nih.gov/pubmed/31655812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503713 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|